InVivoMAb Anti-Mouse IL11RA Antibody (X209) is a highly specific and potent antibody designed for use in biotech research. This antibody targets the Interleukin 11 Receptor Alpha (IL11RA) protein, a crucial component in the IL11 signaling pathway. By binding to IL11RA, this antibody blocks the interaction between IL11 and its receptor, inhibiting downstream signaling processes.
The main application of InVivoMAb Anti-Mouse IL11RA Antibody (X209) is in the study of IL11 signaling and its role in various biological processes. This includes research on inflammation, tissue repair, and cancer progression. IL11 has been implicated in several inflammatory diseases, making this antibody a valuable tool for understanding and potentially treating these conditions.
In addition, InVivoMAb Anti-Mouse IL11RA Antibody (X209) has shown promising results in pre-clinical studies as a potential therapeutic for cancer. IL11 has been shown to promote tumor growth and metastasis, and by blocking its receptor, this antibody may help inhibit these processes.
Experimental use of InVivoMAb Anti-Mouse IL11RA Antibody (X209) has demonstrated its ability to effectively neutralize IL11 signaling in various in vitro and in vivo models. This includes blocking IL11-induced cell proliferation and migration, as well as reducing inflammation in animal models of disease.
InVivoMAb Anti-Mouse IL11RA Antibody (X209) is a reliable and high-quality tool for studying IL11 signaling and its role in disease. Its specificity and potency make it a valuable addition to any biotech research arsenal. Order now and advance your understanding of IL11 and its potential therapeutic applications.
There are no reviews yet.